158.71
price up icon0.08%   0.13
after-market Dopo l'orario di chiusura: 158.72 0.010 +0.01%
loading
Precedente Chiudi:
$158.58
Aprire:
$157.84
Volume 24 ore:
2.09M
Relative Volume:
0.92
Capitalizzazione di mercato:
$27.64B
Reddito:
$15.50B
Utile/perdita netta:
$1.33B
Rapporto P/E:
21.62
EPS:
7.34
Flusso di cassa netto:
$2.16B
1 W Prestazione:
+2.65%
1M Prestazione:
+15.85%
6M Prestazione:
-20.64%
1 anno Prestazione:
-24.93%
Intervallo 1D:
Value
$156.13
$159.62
Intervallo di 1 settimana:
Value
$153.01
$159.62
Portata 52W:
Value
$134.65
$252.88

Iqvia Holdings Inc Stock (IQV) Company Profile

Name
Nome
Iqvia Holdings Inc
Name
Telefono
919-998-2000
Name
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Name
Dipendente
89,000
Name
Cinguettio
@IQVIA_global
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
IQV's Discussions on Twitter

Confronta IQV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.71 27.64B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
410.65 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
201.00 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
530.40 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
118.62 34.24B 6.63B 1.17B 1.19B 4.05

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-25 Downgrade HSBC Securities Buy → Hold
2025-04-10 Downgrade Barclays Overweight → Equal Weight
2025-02-03 Downgrade BTIG Research Buy → Neutral
2024-12-20 Iniziato Stephens Overweight
2024-10-14 Iniziato Redburn Atlantic Buy
2024-09-04 Iniziato RBC Capital Mkts Outperform
2024-07-24 Downgrade Jefferies Buy → Hold
2024-06-06 Iniziato Goldman Buy
2024-02-26 Iniziato Leerink Partners Outperform
2024-02-15 Downgrade Guggenheim Buy → Neutral
2024-02-13 Iniziato BTIG Research Buy
2023-11-02 Downgrade Robert W. Baird Outperform → Neutral
2023-09-06 Iniziato HSBC Securities Buy
2023-03-17 Iniziato Truist Buy
2022-12-06 Iniziato Cowen Outperform
2022-11-17 Downgrade Citigroup Buy → Neutral
2022-08-25 Iniziato Credit Suisse Outperform
2022-07-15 Iniziato SVB Leerink Outperform
2022-05-24 Iniziato Guggenheim Buy
2022-04-29 Aggiornamento Piper Sandler Neutral → Overweight
2022-04-25 Downgrade Wells Fargo Overweight → Equal Weight
2021-08-05 Ripresa Credit Suisse Outperform
2021-04-16 Aggiornamento Stephens Equal-Weight → Overweight
2021-03-08 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-03-03 Iniziato Barclays Overweight
2020-07-07 Iniziato Stephens Equal-Weight
2020-03-02 Iniziato Deutsche Bank Buy
2020-01-08 Iniziato Wells Fargo Overweight
2020-01-07 Iniziato Citigroup Buy
2019-12-13 Aggiornamento CFRA Sell → Hold
2019-11-14 Aggiornamento Wolfe Research Peer Perform → Outperform
2019-06-21 Aggiornamento Mizuho Neutral → Buy
2019-05-28 Iniziato SVB Leerink Outperform
2019-01-18 Aggiornamento Jefferies Hold → Buy
2018-10-09 Iniziato UBS Buy
2018-10-02 Reiterato Robert W. Baird Outperform
2018-07-25 Aggiornamento BofA/Merrill Neutral → Buy
2018-07-25 Reiterato Stifel Buy
2018-07-03 Aggiornamento Raymond James Outperform → Strong Buy
2018-04-13 Aggiornamento Goldman Neutral → Buy
2018-03-07 Aggiornamento SunTrust Hold → Buy
2018-01-19 Iniziato Evercore ISI Outperform
Mostra tutto

Iqvia Holdings Inc Borsa (IQV) Ultime notizie

pulisher
Jun 17, 2025

Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Yahoo Finance

Jun 17, 2025
pulisher
Jun 16, 2025

IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ - Business Wire

Jun 16, 2025
pulisher
Jun 15, 2025

Learn to Evaluate (IQV) using the Charts - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 13, 2025

Park Avenue Securities LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

IQVIA Completes $2 Billion Senior Notes Offering - Global Legal Chronicle

Jun 12, 2025
pulisher
Jun 12, 2025

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - Benzinga

Jun 12, 2025
pulisher
Jun 11, 2025

IQVIA unveils AI agents for life sciences using NVIDIA technology By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

IQVIA Launches New AI Agents for Life Sciences and Healthcare - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

IQVIA unveils AI agents for life sciences using NVIDIA technology - Investing.com

Jun 11, 2025
pulisher
Jun 10, 2025

IQVIA Holdings Stock: Is IQV Underperforming The Healthcare Sector? - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

IQVIA Stock: Stuck In A Time SpiralValue Play Or Bull Trap? - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

IQVIA Holdings Inc (IQV) Trading 3.9% Higher on Jun 10 - GuruFocus

Jun 10, 2025
pulisher
Jun 08, 2025

IQVIA Holdings (IQV) Leads S&P 500 Healthcare Gainers - GuruFocus

Jun 08, 2025
pulisher
Jun 04, 2025

IQVIA Holdings Issues $2 Billion in Senior Notes - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

IQVIA Holdings Inc (IQV) Trading 3.85% Higher on Jun 4 - GuruFocus

Jun 04, 2025
pulisher
Jun 03, 2025

IQVIA to raise $2B via senior notes offering to repay debt - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA announces pricing of senior notes - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Rep. Robert Bresnahan, Jr. Sells Off Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing of Senior Notes - 01net

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Inc. (IQV) Secures $2 Billion in Senior Notes Offering - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Holdings Announces $2 Billion Senior Notes Offering - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing of Senior Notes | IQV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Prices $2 Billion Senior Notes Due 2032 - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Pricing Of Senior Notes - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA prices $2 billion senior notes offering - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA announces offering of senior notes - IQVIA

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Offering of Senior Notes - BioSpace

Jun 02, 2025
pulisher
Jun 02, 2025

Iqvia Plans $2 Billion Notes Offering - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA Announces Offering of Senior Notes | IQV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

IQVIA plans $2 billion senior notes offering by 2032 - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Iqvia Announces Offering Of Senior Notes - marketscreener.com

Jun 02, 2025
pulisher
May 31, 2025

IQVIA Holdings Inc. (NYSE:IQV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

May 31, 2025
pulisher
May 31, 2025

What is Zacks Research’s Forecast for IQVIA Q2 Earnings? - Defense World

May 31, 2025
pulisher
May 27, 2025

IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus

May 27, 2025
pulisher
May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com

May 27, 2025

Iqvia Holdings Inc Azioni (IQV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Iqvia Holdings Inc Azioni (IQV) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
DANHAKL JOHN G
Director
Dec 03 '24
Buy
200.58
1,275
255,740
1,275
Sherbet Eric
See Remarks
Aug 27 '24
Sale
246.33
1,300
320,229
19,536
diagnostics_research MTD
$1,192.85
price up icon 0.65%
$164.16
price down icon 4.49%
diagnostics_research LH
$258.70
price down icon 1.46%
diagnostics_research A
$118.62
price up icon 0.83%
diagnostics_research WAT
$350.01
price up icon 0.93%
Capitalizzazione:     |  Volume (24 ore):